Meet the CEO

44 0
Dr. Pratik Shah
Dr. Pratik Shah

VITAL SIGNS

NAME: Pratik Shah, PhD, MBA

CURRENT POSITION: President, Chief Executive Officer, and Director of Auspex Pharmaceuticals

EDUCATION: PhD in Biochemistry and Molecular Biology and MBA, University of Chicago.

HOBBIES: Spending time with family, traveling the west coast, and reading; recently finished Michael Lewis’ Boomerang.

Dr. Shah strives to integrate his training in the biological sciences with his training in finance in order to bring new therapies to patients with unmet medical needs. In addition to his work with Auspex, Dr. Shah serves on several boards of companies in the life sciences. He served as founding investor in a company called CNS Therapeutics, which focused on developing intrathecal pharmaceuticals. He also co-founded a company building high-end robots to automate pharmaceutical research and spent time at McKinsey & Company serving a variety of clients in the pharmaceutical and medical products area.

Related Post

HD Insights Volume 17 (PDF)

May 30, 2017 0
[pdf-embedder url=”http://huntingtonstudygroup.org/wp-content/uploads/2017/05/HD-Insights-Vol.-17-v.12-FINAL.pdf”] For a non-PDF version of HD Insights Vol. 17, click here.

First-HD Results Released

January 1, 2015 0
Auspex announces promising results from First-HD trial of deuterated tetrabenazine (SD-809) By: Meredith A. Achey, BM On December 16, 2014,…

Largest HD Clinical Trial Halted

September 1, 2014 0
Coenzyme Q10 “very unlikely” to show significant benefit in HD in 2CARE study The largest randomized, controlled trial ever conducted…